Sign in

CIK 0001812364

  • Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 4 Open-market sale Chief Financial Officer sold 13,286 shares at $30.00 ($398,580)
  2. 4 Open-market sale President, R&D sold 10,000 shares at $30.00 ($300,000)
  3. 4 Open-market sale President, R&D sold 10,000 shares at $25.00 ($250,000)
  4. 4 Open-market sale President, R&D sold 8,000 shares at $23.88 ($191,040)
  5. 4 Open-market sale President, R&D sold 22,994 shares at an average $20.94 ($481,577)
  6. 4 Grant or award Chief Administrative Officer acquired 24,170 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Grant or award Chief Financial Officer acquired 39,270 shares (grant or award)
  9. 4 Grant or award President, R&D acquired 64,950 shares (grant or award)
  10. 4 Grant or award Chief Legal Officer acquired 39,270 shares (grant or award)
  11. 4 Grant or award General Counsel acquired 658 shares (grant or award)
  12. 4 Grant or award President and CEO acquired 658 shares (grant or award)
  13. 4 Open-market sale Porter Andy sold 260 shares at $33.10 ($8,606)
  14. 4 Open-market sale Senior Vice President, Finance sold 295 shares at $33.10 ($9,765)
  15. 4 Open-market sale Bergstrom Donald A sold 649 shares at $33.10 ($21,482)
  16. 4 Open-market sale General Counsel sold 295 shares at $33.10 ($9,765)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale Senior Vice President, Finance sold 22,500 shares at $35.40 ($796,500)
  19. 4 Open-market sale General Counsel sold 6,500 shares at $35.42 ($230,230)
  20. 4 Open-market sale Bergstrom Donald A sold 30,000 shares at $34.15 ($1,024,500)

Page 13 of 16 · 320 filings